Cargando…

Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling

BACKGROUND: Glucagon-like peptide-1 (GLP-1) therapies are routinely used for glycaemic control in diabetes and their emerging cardiovascular actions have been a major recent research focus. In addition to GLP-1 receptor activation, the metabolically-inactive breakdown product, GLP-1(9–36)amide, also...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Emma, Tate, Mitchel, Lockhart, Samuel, McPeake, Claire, O’Neill, Karla M., Edgar, Kevin S., Calderwood, Danielle, Green, Brian D., McDermott, Barbara J., Grieve, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832495/ https://www.ncbi.nlm.nih.gov/pubmed/27079193 http://dx.doi.org/10.1186/s12933-016-0386-5

Ejemplares similares

Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix
por: Robinson, Emma, et al.
Publicado: (2015)

Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages
por: Tate, Mitchel, et al.
Publicado: (2015)

Health and social consequences of an alcohol-related admission to critical care: a qualitative study
por: McPeake, Joanne, et al.
Publicado: (2016)

Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase‐induced cardiomyopathy: involvement of mitofusin‐2
por: McLaughlin, Declan, et al.
Publicado: (2017)

GLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?
por: Taing, Meng-Wong, et al.
Publicado: (2014)

Downregulation of PPARα during Experimental Left Ventricular Hypertrophy is Critically Dependent on Nox2 NADPH Oxidase Signalling
por: Harvey, Adam P., et al.
Publicado: (2020)

Signalling pathways activated by glucagon-like peptide-1 (7-36) amide in the rat heart and their role in protection against ischaemia
por: Huisamen, Barbara, et al.
Publicado: (2008)

Emetic Response to T-2 Toxin Correspond to Secretion of Glucagon-like Peptide-(17)(–36) Amide and Glucose-Dependent Insulinotropic Polypeptide
por: Zhang, Jie, et al.
Publicado: (2022)

Substance P and Glucagon-like Peptide-1(7-36) Amide Mediate Anorexic Responses to Trichothecene Deoxynivalenol and Its Congeners
por: Jia, Hui, et al.
Publicado: (2022)

Do alcohol use disorders impact on long term outcomes from intensive care?
por: McPeake, Joanne M, et al.
Publicado: (2015)

COVID‐19: Moving beyond the pandemic
por: McPeake, Joanne, et al.
Publicado: (2020)

The use of imepitoin (Pexion™) on fear and anxiety related problems in dogs – a case series
por: McPeake, Kevin J., et al.
Publicado: (2017)

Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9–36 Amide at the GLP-1 Receptor
por: Li, Naichang, et al.
Publicado: (2012)

Assessing the costs of historical inaction on climate change
por: Sanderson, Benjamin M., et al.
Publicado: (2020)

Absent visitors: the wider implications of COVID-19 on cardiothoracic ICU staff: the VINCI Study
por: Hughes, Leah, et al.
Publicado: (2022)

Rapid systematic review on developing web-based interventions to support people affected by cancer
por: Cooke, Samuel, et al.
Publicado: (2022)

Glucagon-Like Peptide-1 Protects Against Atrial Fibrillation and Atrial Remodeling in Type 2 Diabetic Mice
por: Bohne, Loryn J., et al.
Publicado: (2023)

Intensive care referral and admission: do the criteria for liver disease match?
por: McPeake, J, et al.
Publicado: (2015)

Acute effects of glucagon‐like peptide‐1, GLP‐1(9–36 amide), and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers
por: Bremholm, Lasse, et al.
Publicado: (2017)

Targeting immunometabolism as an anti-inflammatory strategy
por: Pålsson-McDermott, Eva M., et al.
Publicado: (2020)

Diagnostic regimes for urinary tract infection--are research results applied to practice?
por: Crawford, V. L., et al.
Publicado: (1995)

Burnout and Joy in the Profession of Critical Care Medicine
por: Kerlin, Meeta Prasad, et al.
Publicado: (2020)

Understanding the Impact of Critical Illness on Families: A Call for Standardization of Outcomes and Longitudinal Research
por: McPeake, Joanne, et al.
Publicado: (2021)

Development and Psychometric Validation of the Lincoln Canine Anxiety Scale
por: Mills, Daniel S., et al.
Publicado: (2020)

Provision of holistic care after severe COVID-19 pneumonia
por: McPeake, Joanne, et al.
Publicado: (2021)

Learning Systems as a Path to Improve ICU Staff Wellbeing
por: McPeake, Joanne, et al.
Publicado: (2022)

meso-3,6-Dioxopiperazine-2,5-diacetamide
por: Li, Ping, et al.
Publicado: (2011)

Ingestion of coffee polyphenols increases postprandial release of the active glucagon-like peptide-1 (GLP-1(7–36)) amide in C57BL/6J mice
por: Fujii, Yoshie, et al.
Publicado: (2015)

Long term outcomes of critically ill COVID-19 pneumonia patients: early learning
por: McCue, Claire, et al.
Publicado: (2020)

Common Risk Factors for Urinary House Soiling (Periuria) in Cats and Its Differentiation: The Sensitivity and Specificity of Common Diagnostic Signs
por: Barcelos, Ana Maria, et al.
Publicado: (2018)

The Canine Frustration Questionnaire—Development of a New Psychometric Tool for Measuring Frustration in Domestic Dogs (Canis familiaris)
por: McPeake, Kevin J., et al.
Publicado: (2019)

Behavioural and Physiological Correlates of the Canine Frustration Questionnaire
por: McPeake, Kevin J., et al.
Publicado: (2021)

The Relationship between Signs of Medical Conditions and Cognitive Decline in Senior Dogs
por: Wrightson, Rosalind, et al.
Publicado: (2023)

Outpatient directly observed therapy for hepatitis C among people who use drugs: a systematic review and meta-analysis
por: McDermott, Cara L, et al.
Publicado: (2018)

Invited Perspective: Forging a Way Forward Amid the Enduring Impacts of Redlining
por: Buxton, Miatta A., et al.
Publicado: (2023)

Utilisation of existing community rehabilitation services by critical care survivors
por: Soulsby, CR, et al.
Publicado: (2015)

Glucagon reduces airway hyperreactivity, inflammation, and remodeling induced by ovalbumin
por: Insuela, Daniella B. R., et al.
Publicado: (2019)

In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1)
por: Rafferty, Eamon P., et al.
Publicado: (2011)

A silent myocardial infarction in the diabetes outpatient clinic: case report and review of the literature
por: Draman, M S, et al.
Publicado: (2013)

GLP-1(28-36)amide, a Long Ignored Peptide Revisited
por: Zhou, Bilan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u89n650u8p1tch41ge1h111sas